Carcinogenic Assessment of Petroleum Products by Nuclear Magnetic Resonance

(Note: The full text of this document is currently only available in the PDF Version )

David T. Coker, Alexander G. King, Dirk L. Mumford and Craig S. Nessel


Abstract

A method is proposed for improving the assessment of carcinogenicity of petroleum materials by non-animal test means. The proposed method is an extension of the current EU regulatory test method IP 346 which measures a proportion of the polycyclic aromatic compounds present, but does not discriminate between the carcinogenic and the non-carcinogenic species, sometimes resulting in false positive assessments. The proposed method involves the use of high-field proton NMR spectrometry on the IP 346 solvent extract to measure the level of ‘bay region hydrogens’ within polycyclic aromatic molecules. These are structures within the molecule, considered to be directly associated with their carcinogenic potential. Tests on a wide range of petroleum materials using this proton NMR method show that the bay region hydrogen measurement gives greater discrimination between carcinogenic and non-carcinogenic materials than IP 346. The NMR method has not so far given any of the false positives which occur with IP 346 for oils which are not found to be carcinogenic by bioassay. It may also be possible to use the bay region hydrogen measurement as a marker for carcinogenicity in a range of petroleum products which are outside the scope of IP 346.


References

  1. E. Bingham, et al., J. Environ. Pathol. Toxicol., 1980, 3, 483 Search PubMed.
  2. UK Institute of Petroleum. Standard Methods for Analysis and Testing of Petroleum and Related Products. Method IP 346/80, Polycyclic Aromatics in Petroleum Fractions by Dimethyl Sulphoxide—Refractive Index Method Search PubMed.
  3. European Commission Directive 94/69/EC. 19/12/ 1994. 21st Adaptation to Technical Progress of the Dangerous Substances Directive 67/548/EEC.
  4. Report 94/51 ( 1994), Concawe (Oil companies European organisation for environmental and health protection, Brussels).
  5. K. L. Chasey and R. H. McKee, J. Appl. Toxicol., 1993, 13(1), 57 CAS.
  6. G. R. Blackburn, et al., Cell Biol. Toxicol., 1986, 2, 63 CrossRef.
  7. T. A. Roy, et al., Fundam. Appl. Toxicol., 1988, 10, 466 CrossRef.
  8. A. Dipple, in Chemical Carcinogens, ACS Monograph 173, ed. Searle, C. E., American Chemical Society(Washington, DC), 1976, ch. 5, pp. 245–314 Search PubMed.
  9. N. F. Chamberlain, The Practice of NMR Spectroscopy, Plenum Press, London, 1974 Search PubMed.
  10. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 1983, vol. 32 and 1987, supplement 7.
  11. V. A. Kalichevsky and B. A. Stagner, Chemical Refining of Petroleum, Reinhold, New York, 1942, p. 314 Search PubMed.
  12. G. R. Blackburn, et al., US Patent 5 034 119, 1991 Search PubMed.
  13. L. von Meyerinck, et al., KGK Kautschuk Gummi Kunststoffe, 7–8/ 1996, S.514, Huthig GmbH, Heidelberg Search PubMed.
  14. Report 96/62 ( 1996), Concawe (Oil companies European organisation for environmental and health protection, Brussels).
Click here to see how this site uses Cookies. View our privacy policy here.